Media, supplements, and reagents were purchased from Gibco Invitrogen (Karlsruhe, Germany), Sigma Aldrich (Munich, Germany), or Biochrom AG (Berlin, Germany), unless otherwise stated. Primary HCEC isolation is described elsewhere.
12 Primary HCECs and the immortalized HCEC population HCEC-12
13,14 were grown in F99
HCEC (Ham's F12/medium 199, 5% FCS, 20 μg/mL ascorbic acid, 10 ng/mL human recombinant FGF-2, 20 μg/mL human recombinant insulin, 2.5 μg/mL amphotericin B, 50 μg/mL gentamicin). The clonal HCEC lines B4G12 and H9C1
14 were grown in serum- and antibiotic-free growth medium (Human Endothelial-SFM) supplemented with 10 ng/mL FGF-2. For passaging, cells were first incubated in enzyme-free cell dissociation buffer for 2 minutes at room temperature (RT; except H9C1), followed by trypsin/EDTA (0.05%/0.02%) for 2 minutes. Detached cells were collected in F99
HCEC or serum-free protease inhibitor cocktail (cOmplete; 1 tablet/50 mL serum-free medium; Roche Diagnostics, Mannheim, Germany), centrifuged at 100
g for 5 minutes and plated at a density of 2000 cells/cm
2. B4G12 cells were seeded at 4000 cells/cm
2 because of a slower growth rate and the positive effect of higher cell densities on cell viability. All cultures were grown in T25 tissue culture flasks coated with 10 μg laminin and 10 mg chondroitin sulfate solubilized in 1 mL F99 basal medium for 1 hour at RT. Cells were maintained at 37°C in a humidified atmosphere containing 5% CO
2. Growth medium was changed 3× per week.